SK

Sarwavash Kumar

Active Director Director DIN 10661403
DIN 10661403 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Sarwavash Kumar

Data last updated:

Sarwavash Kumar is a Director at Esteve Pharma Limited (since 2024). The company operates in Pharma. Esteve Pharma Limited reported revenue of ₹7.63 Cr (FY 2024).

DIN 10661403
Primary Designation Director
Industry Pharma
First Appointment 10 Jun 2024
Oldest Company Age 10 yrs
Largest company Esteve Pharma Limited · ₹7.63 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Esteve Pharma Limited U74900UR2016PLC001918
Director10 Jun 20242016₹7.63 Cr (FY 2024)Active

Board colleagues of Sarwavash Kumar

NameDINCompanyDesignation
Himanshu Shekhar07433985Esteve Pharma LimitedDirector
Shruti Tiwari07439137Esteve Pharma LimitedDirector

Directorship timeline

Open interactive timeline →
Esteve Pharma Limited
Premium access

Shareholding and investment profile for Sarwavash Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarwavash Kumar

Sarwavash Kumar currently holds 1 directorship: Esteve Pharma Limited (Director, since 10 Jun 2024, revenue ₹7.63 Cr (FY 2024)).

Sarwavash Kumar was first appointed on 10 Jun 2024 as Director at Esteve Pharma Limited.

The current boards of Sarwavash Kumar's companies include Himanshu Shekhar (Esteve Pharma Limited), Shruti Tiwari (Esteve Pharma Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available